T. Rowe Price Associates’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-5,518,932
| Closed | -$90.4M | – | 3034 |
|
|
2021
Q3 | $90.4M | Buy |
5,518,932
+132,629
| +2% | +$2.17M | 0.01% | 800 |
|
|
2021
Q2 | $90.7M | Sell |
5,386,303
-50,595
| -0.9% | -$852K | 0.01% | 814 |
|
|
2021
Q1 | $99.3M | Buy |
5,436,898
+74,254
| +1% | +$1.36M | 0.01% | 779 |
|
|
2020
Q4 | $97.6M | Sell |
5,362,644
-20,922
| -0.4% | -$381K | 0.01% | 730 |
|
|
2020
Q3 | $96M | Sell |
5,383,566
-111,770
| -2% | -$1.99M | 0.01% | 667 |
|
|
2020
Q2 | $98.5M | Sell |
5,495,336
-72,130
| -1% | -$1.29M | 0.01% | 642 |
|
|
2020
Q1 | $84.5M | Buy |
5,567,466
+1,458,068
| +35% | +$22.1M | 0.01% | 619 |
|
|
2019
Q4 | $81.1M | Sell |
4,109,398
-46,969
| -1% | -$927K | 0.01% | 736 |
|
|
2019
Q3 | $71.5M | Sell |
4,156,367
-19,531
| -0.5% | -$336K | 0.01% | 733 |
|
|
2019
Q2 | $73.9M | Sell |
4,175,898
-1,780,699
| -30% | -$31.5M | 0.01% | 735 |
|
|
2019
Q1 | $121M | Buy |
+5,956,597
| New | +$121M | 0.02% | 587 |
|